ClinInnov SRL
ClinInnov reported total assets of 361,049 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Jun 2026).
The score of ClinInnov shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ClinInnov's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Jun 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
ClinInnov's financial analysis
- Solvency65.8%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ClinInnov
ClinInnov's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0805.203.928
- VAT number
- BE0805203928
- Peppol
- Registered · 0208:0805203928 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Aug 2023
- Registered office
- 5590 Ciney
- Latest accounts
- 2025 · filed on 05 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
ClinInnov (SRL) has been based in Ciney since 2023, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 124,241 € and equity of 237,541 €; its revenue is not published. Its solvency stands at 65.8%, above the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ClinInnov
Companies in the same business, of comparable size and area, outside its group.
- Biokey Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 2,606 €
- Loxia Consulting Research and experimental development on natural sciences and engineering Watermael-Boitsfort · balance sheet 325,836 €
- EDF Quality Services Research and experimental development on natural sciences and engineering Zoersel · balance sheet 313,863 €
- Certor Research and experimental development on natural sciences and engineering Mechelen · balance sheet 505,224 €
- Opero Research and experimental development on natural sciences and engineering Grimbergen · balance sheet 225,981 €
- Clino Consult Research and experimental development on natural sciences and engineering Beveren-Kruibeke-Zwijndrecht · balance sheet 191,749 €
- Bio-Perspectives Research and experimental development on natural sciences and engineering Ixelles · balance sheet 206,760 €
- Thalen Biotech Consultancy Research and experimental development on natural sciences and engineering Frasnes-lez-Anvaing · balance sheet 215,550 €
Frequently asked questions about ClinInnov
What is the revenue of ClinInnov?
ClinInnov files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ClinInnov?
In Belgium, the VAT number is the company number prefixed with BE: BE0805203928 for ClinInnov, if the company is VAT-registered. Its company number (CBE) is 0805.203.928.
Where is the registered office of ClinInnov?
According to the CBE register, the registered office of ClinInnov is in 5590 Ciney.
What is the equity of ClinInnov?
At the close of the 2025 financial year, the equity of ClinInnov amounts to 237,541 €, a solvency of 65.8% of total assets.
Who manages ClinInnov?
The register lists 1 active mandates at ClinInnov. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ClinInnov
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →